| Pharmaceutical Information |
| Drug Name |
Indinavir sulfate |
| Drug ID |
BADD_D01151 |
| Description |
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. [PubChem] |
| Indications and Usage |
Indinavir is an antiretroviral drug for the treatment of HIV infection. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
J05AE02 |
| DrugBank ID |
DB00224
|
| KEGG ID |
D00897
|
| MeSH ID |
D019469
|
| PubChem ID |
5462355
|
| TTD Drug ID |
D0V7CF
|
| NDC Product Code |
0006-0573; 0006-0571 |
| Synonyms |
Indinavir | MK-639 | MK 639 | MK639 | L-735 524 | L 735 524 | L735 524 | L-735,524 | L 735,524 | L735,524 | Crixivan | Indinavir Sulfate | Sulfate, Indinavir | Indinavir, Sulfate (1:1) |
|
| Chemical Information |
| Molecular Formula |
C36H49N5O8S |
| CAS Registry Number |
157810-81-6 |
| SMILES |
CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=
C5.OS(=O)(=O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
|
|
| ADRs Induced by Drug |
|
|
